Saddlepoint p-values for the class of bivariate two-sample tests under generalized randomized block design.

IF 1.3 4区 医学 Q4 PHARMACOLOGY & PHARMACY
Abd El-Raheem M Abd El-Raheem, Ibrahim A A Shanan, Mona Hosny
{"title":"Saddlepoint p-values for the class of bivariate two-sample tests under generalized randomized block design.","authors":"Abd El-Raheem M Abd El-Raheem, Ibrahim A A Shanan, Mona Hosny","doi":"10.1080/10543406.2025.2592617","DOIUrl":null,"url":null,"abstract":"<p><p>Bivariate data arise in several research fields, such as clinical trials and reliability studies. In clinical trials, patients are distributed into treatment groups using randomization designs, which prevent selection bias and incidental bias. Generalized randomized block design is among clinical trials' most famous and widely used randomization designs. This article investigates the use of the saddlepoint method to approximate the underlying permutation distributions of bivariate two-sample tests under a generalized randomized block design. Additionally, the saddlepoint method is utilized to approximate the tail probability of these tests. Through comprehensive simulation studies, the accuracy of this approximation method is thoroughly evaluated, revealing a significant improvement in precision compared to the asymptotic normal approximation.</p>","PeriodicalId":54870,"journal":{"name":"Journal of Biopharmaceutical Statistics","volume":" ","pages":"1687-1698"},"PeriodicalIF":1.3000,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Biopharmaceutical Statistics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/10543406.2025.2592617","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/12/5 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Bivariate data arise in several research fields, such as clinical trials and reliability studies. In clinical trials, patients are distributed into treatment groups using randomization designs, which prevent selection bias and incidental bias. Generalized randomized block design is among clinical trials' most famous and widely used randomization designs. This article investigates the use of the saddlepoint method to approximate the underlying permutation distributions of bivariate two-sample tests under a generalized randomized block design. Additionally, the saddlepoint method is utilized to approximate the tail probability of these tests. Through comprehensive simulation studies, the accuracy of this approximation method is thoroughly evaluated, revealing a significant improvement in precision compared to the asymptotic normal approximation.

广义随机区组设计下二元双样本检验类的鞍点p值。
双变量数据出现在一些研究领域,如临床试验和可靠性研究。在临床试验中,使用随机化设计将患者分配到治疗组,以防止选择偏倚和偶然偏倚。广义随机区组设计是临床试验中最著名、应用最广泛的随机化设计之一。本文研究了在广义随机块设计下使用鞍点法近似二元双样本检验的潜在排列分布。此外,利用鞍点法来近似这些试验的尾概率。通过全面的仿真研究,对该近似方法的精度进行了全面评估,与渐近正态近似相比,精度有了显著提高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Biopharmaceutical Statistics
Journal of Biopharmaceutical Statistics 医学-统计学与概率论
CiteScore
2.50
自引率
18.20%
发文量
71
审稿时长
6-12 weeks
期刊介绍: The Journal of Biopharmaceutical Statistics, a rapid publication journal, discusses quality applications of statistics in biopharmaceutical research and development. Now publishing six times per year, it includes expositions of statistical methodology with immediate applicability to biopharmaceutical research in the form of full-length and short manuscripts, review articles, selected/invited conference papers, short articles, and letters to the editor. Addressing timely and provocative topics important to the biostatistical profession, the journal covers: Drug, device, and biological research and development; Drug screening and drug design; Assessment of pharmacological activity; Pharmaceutical formulation and scale-up; Preclinical safety assessment; Bioavailability, bioequivalence, and pharmacokinetics; Phase, I, II, and III clinical development including complex innovative designs; Premarket approval assessment of clinical safety; Postmarketing surveillance; Big data and artificial intelligence and applications.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书